Skip to content Skip to footer

MGC Pharmaceuticals to be first Cannabis Company Listed on London Stock Exchange

MGC Pharmaceuticals to be first Cannabis Company Listed on London Stock Exchange
Share this story
Share on twitter
Share on linkedin
Share on email

George Brown


 

The LSE represents the largest exchange in Europe, meaning MGC Pharma and other cannabis companies which gain listing, will have the opportunity to generate never-before-seen levels of investment from across the continent, whilst gaining greater exposure to traditional investment communities.

The company said it has secured binding commitments to raise £6.5 million through a placing to coincide with its listing and that a total of 441 million new shares will be issued at £0.01475 each.

Co-Founder and Managing Director of MGC Pharma, Roby Zomer, said:

“It took us over 18 months to complete this process because we wanted to move onto the next step. We are listed in Australia but we operate in Europe and our main facilities are in Slovenia so we want to be in closer proximity to our investors and shareholders.

“The UK stock market is already familiar with the story cannabis in the pharmaceutical sector and therefore we will have more understanding of our strategy and agenda.”

The timing of the listing comes at a good time for the industry, as a wave of cannabis legalisation initiatives are sweeping the US, following the election of Joe Biden as President.

A number of other cannabis companies are expected to join the LSE in the coming weeks, which is expected to drive a surge of interest in the wider cannabis industry across Europe.

Recent posts
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad

Catch up on our newest articles that you might have missed

Untitled design (11)
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
The relatively close integration of medical cannabis into the European healthcare systems has contributed to a patient population and purchasing...
il-vagabiondo-Q7QCj-9-q3I-unsplash
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
Underlining the cautious approach Europe is taking to the liberalisation of medical cannabis are the pilot trial access schemes for...
vincent-ghilione-z54zUmYA9f8-unsplash
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
Last week the first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland was approved by...
thomas-kelley--8iE9ykf3Us-unsplash
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad
The recent publishing of the list of CBD products with a valid Novel Foods application by the UK’s Food Safety...